Keyword: Biocides

Chemistry & Life Sciences

Beyond REACh: Nanomaterials in the European Union

27.07.2015 - Companies manufacturing, importing or distributing nanomaterials into the territory of the European Union do not only have to comply with the Registration, Evaluation...

Chemistry & Life Sciences

Saltigo Offers Intelligent Custom Manufacturing

22.06.2015 - “Our core business primarily revolves around custom manufacturing, particularly for the agrochemical industry. We have had success in the past and the outlook for the future looks...

Chemistry & Life Sciences

Roles Under REACh (Part 3)

23.03.2015 - Regulation (EC) No. 1907/2006 of the European Parliament and of the Council, well-known as the REACh regulation, or Registration, Evaluation, Authorization and Restriction of...

Plant Construction & Process Technology

Essential Ingredients

08.05.2014 - Understanding The Source - Classification of today's supply chain - regarding all organic chemicals involved in the manufacturing of an API - is a useful tool for demonstrating...

Chemistry & Life Sciences

European Chemicals Agency and The Appeals Process

16.12.2013 - Little-Known Step - More than six years after the REACH regulation went into force, perhaps the least-known part of the regulation is the Board of Appeal (BoA) of the European...

News

Lanxess Acquires Asian Biocide Specialist PCTS

05.04.2013 - The German specialty chemicals group Lanxess has acquired Singapore-based PCTS Specialty Chemicals for an undisclosed amount. The transaction closes with immediate effect. PCTS...

News

New ECHA Committee Starts Working for Safe Biocidal Products

29.03.2013 - The first meeting of the Biocidal Products Committee from 26 to 27 March 2013 was one of the big milestones in preparation for the new regulation. The committee has started work on...

News

Lonza Begins Tender Offer To Acquire Arch Chemicals

19.07.2011 - Biocides company Arch Chemicals announced that Lonza's subsidiary, Lonza LG Acquisition Corp., has commenced the previously announced offer to acquire all of the outstanding shares...